Pulmonary Hypertension vs. Systemic Hypertension: Key Differences in Causes, Symptoms, and Management

Pulmonary hypertension (PH) and systemic (essential) hypertension (HTN) both involve elevated blood pressure but affect different vascular beds and have distinct pathophysiology.

Pulmonary Hypertension (WHO Group 1–5)

  • Definition: Mean pulmonary arterial pressure (mPAP) >20 mmHg at rest (RHC).
  • Pathology: Pulmonary vascular remodeling → increased pulmonary vascular resistance (PVR) → right ventricular (RV) strain/failure.
  • Causes: Idiopathic/heritable (PAH), left heart disease (Group 2), lung disease/hypoxia (Group 3), chronic thromboembolic (Group 4), multifactorial (Group 5).
  • Symptoms: Exertional dyspnea (hallmark), fatigue, syncope, chest pain, peripheral edema, RV heave, loud P2.
  • Diagnosis: Echo (estimated RVSP), right heart catheterization (gold standard), V/Q scan (CTEPH).
  • Treatment: PAH‑specific (ERAs, PDE5i, prostacyclins, sGC stimulators); treat underlying cause for Groups 2–5; anticoagulation (CTEPH); lung transplant (end‑stage).

Systemic Hypertension

  • Definition: Office BP ≥130/80 mmHg (ACC/AHA) or ≥140/90 (ESC/JNC).
  • Pathology: Increased systemic vascular resistance → left ventricular hypertrophy → heart failure, stroke, CKD, CAD.
  • Risk factors: Age, obesity, salt, alcohol, inactivity, genetics, renal/endocrine disorders.
  • Symptoms: Often asymptomatic; severe HTN → headache, visual changes, epistaxis.
  • Treatment: Lifestyle (DASH, Na⁺<2.3g, exercise, weight loss, EtOH moderation) + antihypertensives (ACEi/ARB, CCB, thiazide, β‑blocker per guidelines).

Key Distinctions

Both require specialist management. PH carries higher short‑term mortality if untreated; systemic HTN drives long‑term cardiovascular morbidity.

Hypertension - Related Articles

Health Sciences © https://www.222health.com

FeaturePulmonary HypertensionSystemic Hypertension
Vascular bedPulmonary arteriesSystemic arteries
Primary ventricle affectedRight ventricleLeft ventricle
Common symptomsDyspnea, syncope, RV failure signsOften silent; headache, vision changes
Diagnostic gold standardRight heart catheterizationAmbulatory/home BP monitoring
Disease‑specific drugsPAH‑targeted (ERAs, PDE5i, prostanoids)ACEi, ARB, CCB, thiazides, etc.